Machine Learning

A new partnership is trading vague online metrics for real-world visits, proving advertising's impact and reshaping how tourist destinations spend money.

GMMB promotes digital strategist Erica Monteith and ad maker Jodi Quintero, signaling a deep investment in data-driven innovation and powerful advocacy.

The digital health giant now offers a 50+ cancer blood test, promising early detection. But experts caution on its limits and lack of FDA approval.

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

A Chinese tech firm plans to bring its automated parking solutions to NYC and LA, facing a crowded market, financial hurdles, and geopolitical scrutiny.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A top KLAS award reveals a new era in healthcare cybersecurity, where measurable risk reduction and financial value are becoming more important than ever.

The world's largest equipment rental firm adds a Silicon Valley AI expert to its board, signaling a major push to digitize the heavy equipment industry.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

The AI firm has fully deployed an AI agent to assist recruiters in live interviews, a move that promises efficiency but raises critical ethical questions.

R1 secures 'Best in KLAS' for the 7th straight year. We dive into the AI tech and expert services transforming hospital finances across the U.S.

At SEMICON Korea, Axcelis launches its Purion H6, a critical tool for manufacturing the advanced semiconductors that will define the rapidly expanding AI era.

Caribou Biosciences unveils new data showing its 'off-the-shelf' CAR-T cells achieve deep, lasting responses in lymphoma and myeloma clinical trials.

Global security leader Securitas acquires OSINT platform Liferaft, signaling a bold move to fuse digital threat intelligence with physical security services.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

A powerful new genomic tool is turning genetic doubt into diagnostic certainty, helping thousands of patients understand their true hereditary cancer risk.

With a 90% clinical trial failure rate, BullFrog AI is launching a new tool to help drugmakers make smarter, risk-balanced R&D decisions.